Approccio diagnostico-terapeutico della Sindrome di McCune-Albright

Turan S, Bastepe M (2015) GNAS spectrum of disorders. Curr Osteoporos Rep 13(3):146–158

Kim IS, Kim ER, Nam HJ et al. (1999) Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res 52(5):235–240

Estrada A, Boyce AM, Brillante BA et al. (2016) Long-term outcomes of letrozole treatment for precocious puberty in girls with McCune-Albright syndrome. Eur J Endocrinol 175(5):477–483

Tessaris D, Matarazzo P, Mussa A et al. (2012) Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Endocr J 59(2):111–117

Tessaris D, Corrias A, Matarazzo P et al. (2012) Thyroid abnormalities in children and adolescents with McCune-Albright syndrome. Horm Res Paediatr 78(3):151–157

Tessaris D, Boyce AM, Zacharin M et al. (2018) Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome. Clin Endocrinol (Oxf) 89(1):56–64

Brown RJ, Kelly MH, Collins MT (2010) Cushing syndrome in the McCune-Albright syndrome. J Clin Endocrinol Metab 95(4):1508–1515

Collins MT, Singer FR, Eugster E (2012) McCune-Albright syndrome and the extraskeletal manifestations of fibrous dysplasia. Orphanet J Rare Dis 7(Suppl 1):S4